News
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...
The maker of Ozempic and Wegovy said that after a 68-week trial, obese and overweight patients who took CagriSema and followed a treatment plan lost an average of 22.7% of their body weight compared ...
Contest Honors Hospitals for Healing Design, Compassionate Care, and Community ImpactAtlanta, GA, June 23, 2025 (GLOBE NEWSWIRE) -- Soliant Health, a leading healthcare and education staffing provider ...
Novo Nordisk (NVO) and Hims and Hers Health (HIMS) shares are sinking on an ended partnership, with the former also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results